Grants and Contributions:

Title:
228852
Agreement Number:
228852
Agreement Value:
$200,000.00
Agreement Date:
Sep 14, 2026 - Jan 31, 2029
Description:
Support to commercialize an oral salmon vaccine
Organization:
Atlantic Canada Opportunities Agency
Expected Results:

To achieve one or more of the following departmental results, i) Businesses are innovative and growing in Atlantic Canada, ii) Businesses invest in the development and commercialization of innovative technologies in Atlantic Canada; and iii) Communities are economically diversified in Atlantic Canada.

Location:
Sydney, Nova Scotia, CA B1M 1A2
Reference Number:
276-2026-2027-Q2-00213
Agreement Type:
Contribution
Report Type:
Grants and Contributions
Recipient Business Number:
781340146
Recipient Type:
For-profit organization
Additional Information:

The assistance type is Repayable Contribution. The total government funding is $300,000.00.

Amendment Date
0001-01-01T00:00:00
Recipient's Operating Name:
SEVO Bioscience Inc.
Recipient's Legal Name:
SEVO Bioscience Inc.
Program:
REGI - Business Scale-Up and Productivity (BSP)
Program Purpose:

To invest in and support businesses at various stages of development, including high-growth firms to accelerate their growth and assist them in scaling up, enhance their productivity and competitiveness in both domestic and global markets.

Amendments: